Kepler Universitätsklinikum Med Campus III.
About Kepler Universitätsklinikum Med Campus III.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Medtronic Cardiac Rhythm and Heart Failure
5
Bayer
4
Alliance Foundation Trials, LLC.
1
Universität des Saarlandes
1
Vivostat
1
Clinical Trials at Kepler Universitätsklinikum Med Campus III.
During the past decade, Kepler Universitätsklinikum Med Campus III. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Micra Atrial Tracking Using a Ventricular Accelerometer Study
2017-07-10
2017-11-24
Completed
70
Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients
2017-12-05
2024-11-01
Recruiting
388
Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
2020-06-17
2022-02-21
Completed
1,601
This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
2020-07-07
2022-12-28
Terminated
90
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kepler Universitätsklinikum Med Campus III." #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials, followed by "Bayer" with 4 trials
sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Universität des Saarlandes" with 1 trials sponsored and "Vivostat"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kepler Universitätsklinikum Med Campus III."
#1 collaborator was "AF Schimetta GMbH" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "European Commission" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Kepler Universitätsklinikum Med Campus III.
According to Clinical.Site data, the most researched conditions in "Kepler Universitätsklinikum Med Campus III." are
"Atrioventricular Conduction Block" (2 trials), "Acute Myocardial Infarction" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Anastomotic Leak Rectum" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Kepler Universitätsklinikum Med Campus III." in a lesser frequency.
Clinical Trials Intervention Types at Kepler Universitätsklinikum Med Campus III.
Most popular intervention types in "Kepler Universitätsklinikum Med Campus III." are "Device" (6 trials), "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials), "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials), "Arctic Front™ Cardiac Cryoablation Catheter System" (1 trials), "BAY1097761 Active Dose 1" (1 trials) and "BAY1097761 Active Dose 2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kepler Universitätsklinikum Med Campus III.
The vast majority of trials in "Kepler Universitätsklinikum Med Campus III." are
11 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Kepler Universitätsklinikum Med Campus III.
Currently, there are NaN active trials in "Kepler Universitätsklinikum Med Campus III.".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kepler Universitätsklinikum Med Campus III.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kepler Universitätsklinikum Med Campus III., 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".